Evvy
United States · Healthtech · Biotech
Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.
A detailed test from a home-collected sample
A customer collects a vaginal swab at home and sends it to Evvy’s lab for metagenomic sequencing. The test analyzes hundreds of bacteria and fungi, then provides clinician-reviewed results and a personalized plan of next steps. This gives patients and their providers a broader view of the vaginal microbiome than a test focused on only a small set of organisms.
Testing connects to care and research
After results, patients can book health-coach support and may be eligible for provider-directed prescription care; eligibility depends on the patient and treatment is separate from the test purchase. Evvy also invites customers to contribute anonymized data to research on the vaginal microbiome and related conditions. The company is expanding this dataset and research into additional areas of women’s health, including fertility.
- Headquarters
- New York, United States
- Sample method
- At-home vaginal swab
- Care options
- Clinician review, health coaching and eligible prescription treatment
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $40M | Catalio Capital Management — LeadAlumni Ventures — ParticipantAmboy Street Ventures — ParticipantBBG Ventures — ParticipantFlywheel Ventures — ParticipantForeground Capital — ParticipantGeneral Catalyst — ParticipantIngeborg — ParticipantLabcorp Venture Fund — ParticipantLeft Lane Capital — ParticipantMuse Capital — ParticipantRethink Impact — Participant |